StarsourceMultitrade
Ticker > Company >

StarsourceMultitrade share price

Starsource Multitrade Ltd.

BSE: 506365 SECTOR: Pharmaceuticals & Drugs  8.6 K   16   0

83.65
-3.96 (-4.52%)
BSE: Today, 12:57 PM

Price Summary

Today's High

₹ 83.65

Today's Low

₹ 83.61

52 Week High

₹ 152.9

52 Week Low

₹ 75

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 12.55 Cr.

Enterprise Value

₹ 1.92 Cr.

No. of Shares

0.15 Cr.

P/E

0

P/B

9.81

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.53

CASH

₹ 10.62 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

27.89 %

EPS (TTM)

₹  -79.03

Sales Growth

0%

ROE

2.64 %

ROCE

3.84%

Profit Growth

-71.49 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 YearNA

Profit Growth

1 Year-71.49%
3 Year-15.14%
5 Year-3.79%

ROE%

1 Year2.64%
3 Year4.29%
5 Year4.03%

ROCE %

1 Year3.84%
3 Year6.03%
5 Year4.84%

Debt/Equity

0

Price to Cash Flow

-44.42

Interest Cover Ratio

796.6326

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2026 27.89 0.00
Dec 2025 27.89 0.00
Sep 2025 27.89 0.00
Jun 2025 27.89 0.00
Mar 2025 27.89 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company’s PEG ratio is 0.0148046995268808.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Company has a healthy liquidity position with current ratio of 52.6951.

 Limitations

  • The company has shown a poor profit growth of -15.137518263253% for the Past 3 years.
  • Company has a poor ROE of 4.29456666666667% over the past 3 years.
  • Company has negative cash flow from operations of -0.28245.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 0 0 0.53 0 0
Total Expenditure 0.02 11.83 0.43 0.09 0.07
Operating Profit -0.02 -11.83 0.1 -0.09 -0.07
Other Income -0.16 0.02 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.18 -11.81 0.1 -0.09 -0.07
Tax 0.16 0 0 0 0
Profit After Tax -0.34 -11.81 0.1 -0.09 -0.07
Adjusted EPS (Rs) -2.26 -78.7 0.65 -0.58 -0.47

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 0 0 0 0 0
Total Expenditure 0.33 0.5 0.61 0.18 0.29
Operating Profit -0.33 -0.5 -0.61 -0.18 -0.29
Other Income 0.67 0.88 0.71 1.84 0.8
Interest 0 0 0.01 0 0
Depreciation 0.02 0.02 0.01 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.31 0.36 0.07 1.64 0.5
Tax 0.06 -0.2 0.03 0.44 0.16
Net Profit 0.25 0.56 0.05 1.2 0.34
Adjusted EPS (Rs.) 1.67 3.73 0.32 8 2.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.5 1.5 1.5 1.5 1.5
Total Reserves 9.49 10.05 10.1 11.3 11.64
Borrowings 0 0 0 0 0
Other N/C liabilities 0 -0.26 -0.24 0.03 -0.01
Current liabilities 0.06 0.11 0.02 0.18 0.21
Total Liabilities 11.05 11.4 11.38 13.02 13.34
Assets
Net Block 0.05 0.04 0.03 0.02 0.01
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.04 2.94 3.03 4.4 0.01
Loans & Advances 0 2.12 2.2 2.35 2.51
Other N/C Assets 0 0 0 0 0
Current Assets 10.96 6.3 6.13 6.25 10.81
Total Assets 11.05 11.4 11.38 13.02 13.34
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.31 0.36 0.07 1.64 0.5
Adjustment -0.51 -0.65 -0.7 -0.84 -0.56
Changes in Assets & Liabilities -0.13 0.02 -0.05 0.09 -0.02
Tax Paid -0.09 -0.06 -0.01 -0.17 -0.2
Operating Cash Flow -0.41 -0.33 -0.68 0.72 -0.28
Investing Cash Flow -0.19 0.97 0.63 -0.52 10.46
Financing Cash Flow 1.96 -2.12 -0.08 -0.15 -0.16
Net Cash Flow 1.36 -1.49 -0.13 0.05 10.02

Corporate Actions

Investors Details

PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
promoters 27.89 27.89 27.89 27.89 27.89
atibha agriseeds private ... - - 27.89 27.89 27.89
citric india ltd 24.63 24.63 - - -
shanta somani 3.25 3.25 - - -
PARTICULARS Mar 2025% Jun 2025% Sep 2025% Dec 2025% Mar 2026%
investors 72.11 72.11 72.11 72.11 72.11
kshemtech media private l... - 3.63 3.63 3.63 3.63
ravindra somani 3.16 - 3.16 3.16 3.16
sudhanshu kanda - - 1.50 1.62 1.70
sudhir harilal kale 2.33 - 2.33 2.33 2.33
divya kanda - - - 1.13 -
ravindra somani - 3.16 - - -
sudhanshu kanda - 1.28 - - -
sudhir harilal kale - 2.33 - - -
llp 0.13 - - - -
shree consultation and s... 3.63 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Starsource Multitrade informs about newspaper advertisement 30 May, 1:11 PM Starsource Multitrad - Quaterly Results 13 Feb, 12:00 AM Chemo Pharma Laboratories informs about disclosure 16 Oct, 2:58 PM Chemo Pharma Laboratories informs about appointment of CS cum CO 12 Sep, 5:18 PM Chemo Pharma Labs - Quaterly Results 12 Aug, 7:09 PM Chemo Pharma Labs - Quaterly Results 12 Aug, 7:09 PM Chemo Pharma Laboratories informs about board meeting 28 Jul, 5:24 PM Chemo Pharma Laboratories informs about disclosure 15 Jul, 10:23 AM Chemo Pharma Laboratories informs about disclosure 15 Jul, 10:22 AM Chemo Pharma Laboratories informs about closure of trading window 31 Mar, 3:26 PM Chemo Pharma Labs - Quaterly Results 27 Jan, 5:03 PM Chemo Pharma Labs - Quaterly Results 27 Jan, 5:03 PM Chemo Pharma Labs - Quaterly Results 27 Jan, 5:03 PM Chemo Pharma Labs - Quaterly Results 29 Oct, 12:00 PM Chemo Pharma Laboratories informs about disclosure 8 Oct, 4:54 PM Chemo Pharma Labs - Quaterly Results 29 Jul, 5:34 PM Chemo Pharma Labs - Quaterly Results 29 Jul, 5:34 PM Chemo Pharma Labs - Quaterly Results 29 Jul, 5:34 PM Chemo Pharma Laboratories informs about compliance certificate 2 Jul, 4:20 PM Chemo Pharma Labs - Quaterly Results 27 May, 5:31 PM Chemo Pharma Labs - Quaterly Results 27 May, 5:31 PM Chemo Pharma Labs - Quaterly Results 27 May, 5:31 PM Chemo Pharma Laboratories informs about loss of share certificates 23 Apr, 4:59 PM Chemo Pharma Labs - Quaterly Results 29 Jan, 5:17 PM Chemo Pharma Labs - Quaterly Results 29 Jan, 5:17 PM Chemo Pharma Labs - Quaterly Results 29 Jan, 5:17 PM Chemo Pharma Labs - Quaterly Results 27 Oct, 5:19 PM Chemo Pharma Labs - Quaterly Results 27 Oct, 5:19 PM Chemo Pharma Labs - Quaterly Results 27 Oct, 5:19 PM Chemo Pharma Laboratories informs about board meeting 16 Oct, 4:51 PM Chemo Pharma Laboratories informs about declaration of non-applicability of disclosure 9 Oct, 5:06 PM Chemo Pharma Labs - Quaterly Results 27 Jul, 5:22 PM Chemo Pharma Labs - Quaterly Results 27 Jul, 5:22 PM Chemo Pharma Labs - Quaterly Results 27 Jul, 5:22 PM Chemo Pharma Labs - Quaterly Results 24 May, 5:46 PM Chemo Pharma Labs - Quaterly Results 24 May, 5:46 PM Chemo Pharma Laboratories informs about board meeting 15 May, 4:17 PM Chemo Pharma Laboratories informs about confirmation certificate 10 Apr, 5:01 PM Chemo Pharma Laboratories informs about newspaper advertisement 1 Feb, 5:22 PM Chemo Pharma Labs - Quaterly Results 31 Jan, 5:00 PM Chemo Pharma Labs - Quaterly Results 31 Jan, 5:00 PM Chemo Pharma Labs - Quaterly Results 31 Jan, 5:00 PM Chemo Pharma Laboratories informs about trading window closure 29 Dec, 2:19 PM Chemo Pharma Labs - Quaterly Results 20 Oct, 5:05 PM Chemo Pharma Labs - Quaterly Results 20 Oct, 5:05 PM Chemo Pharma Labs - Quaterly Results 28 Jul, 5:18 PM Chemo Pharma Labs - Quaterly Results 28 Jul, 5:18 PM Chemo Pharma Labs - Quaterly Results 28 Jul, 5:18 PM Chemo Pharma Laboratories informs about compliances certificate 4 Jul, 5:07 PM Chemo Pharma Laboratories informs about compliance certificate 7 Apr, 5:05 PM

StarsourceMultitrade Stock Price Analysis and Quick Research Report. Is StarsourceMultitrade an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse StarsourceMultitrade. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). StarsourceMultitrade has a PE ratio of -1.05841461763586 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. StarsourceMultitrade has ROA of 2.5968% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. StarsourceMultitrade has a Current ratio of 52.6951.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. StarsourceMultitrade has a ROE of 2.6377%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. StarsourceMultitrade has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: StarsourceMultitrade has reported revenue growth of 0% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of StarsourceMultitrade for the current financial year is 0%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for StarsourceMultitrade is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of StarsourceMultitrade is Rs -79.0333. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of StarsourceMultitrade in Ticker for free. Also, one can get the intrinsic value of StarsourceMultitrade by using Valuation Calculators, which are available with a Finology ONE subscription. 

StarsourceMultitrade FAQs

Q1. What is StarsourceMultitrade share price today?
Ans: The current share price of StarsourceMultitrade is Rs 83.65.

Q2. What is the market capitalisation of StarsourceMultitrade?
Ans: StarsourceMultitrade has a market capitalisation of Rs 12.5475 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of StarsourceMultitrade?
Ans: The PE ratio of StarsourceMultitrade is -1.05841461763586 and the P/B ratio of StarsourceMultitrade is 9.80564542598584, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of StarsourceMultitrade share?
Ans: The 52-week high share price of StarsourceMultitrade is Rs 152.9, and the 52-week low share price of StarsourceMultitrade is Rs 75.

Q5. Does StarsourceMultitrade pay dividends?
Ans: Currently, StarsourceMultitrade does not pay dividends. Dividend yield of StarsourceMultitrade is around 0%.

Q6. What are the face value and book value of StarsourceMultitrade shares?
Ans: The face value of StarsourceMultitrade shares is Rs 10, while the book value per share of StarsourceMultitrade is around Rs 8.5308. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of StarsourceMultitrade?
Ans: StarsourceMultitrade has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of StarsourceMultitrade?
Ans: The ROE of StarsourceMultitrade is 2.6377% and ROCE of StarsourceMultitrade is 3.8439%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is StarsourceMultitrade a good buy for the long term?
Ans: The StarsourceMultitrade long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is StarsourceMultitrade undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the StarsourceMultitrade appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check StarsourceMultitrade’s financials?
Ans: You can review StarsourceMultitrade’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about StarsourceMultitrade
X